BioMedNewsBreaks — NextPlat Corp. (NASDAQ: NXPL, NXPLW) Subsidiary PharmcoRx Awarded Multi-State Prescription Fulfillment Contract From DevotedDOc 

NextPlat (NASDAQ: NXPL, NXPLW), a global provider of healthcare and technology solutions through e-commerce and retail channels, announced that its PharmcoRx subsidiary has secured an exclusive multi-state prescription fulfillment services contract from DevotedDOc, a virtual medical group specializing in urgent care, Medication-Assisted Treatment for opioid use disorder, and compounded alternatives to GLP-1 therapies for weight loss and hormone replacement therapy. PharmcoRx will begin serving patients in Florida and Georgia in November, with plans to expand nationally across its licensed territories. Vice President of Healthcare Operations Birute Norkute said the partnership underscores NextPlat’s commitment to improving access to rapid, affordable, and quality medical care for patients nationwide.

To view the full press release, visit: https://ibn.fm/hKXZm

About NextPlat Corp.

Nextplat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care.

NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN